Literature DB >> 30266198

Management of Heart Failure in the Emergency Department Setting: An Evidence-Based Review of the Literature.

Brit Long1, Alex Koyfman2, Michael Gottlieb3.   

Abstract

BACKGROUND: Acute heart failure (AHF) is a common presentation to the emergency department (ED), with the potential to cause significant morbidity and mortality. It is important to tailor treatments to the appropriate type of heart failure.
OBJECTIVES: This review provides an evidence-based summary of the current ED management of acute heart failure. DISCUSSION: Heart failure can present along a spectrum, especially in acute exacerbation. Treatment should focus on the underlying disease process, with guidelines focusing primarily on blood pressure and hemodynamic status. Treatment of patients with mild AHF exacerbations often focuses on intravenous diuretics. Patients with AHF with flash pulmonary edema should receive nitroglycerin and noninvasive positive pressure ventilation, with consideration of an angiotensin-converting enzyme inhibitor, while monitoring for hypotension. Patients with hypotensive AHF should receive emergent specialty consultation and an initial fluid bolus of 250-500 mL, followed by initiation of inotropic agents with or without vasopressors. Dobutamine is the inotrope of choice in these patients, with norepinephrine recommended if blood pressure support is needed. If noninvasive positive pressure ventilation is required, providers should monitor closely for acute decompensation. Mechanical circulatory support devices may be considered as a bridge to further therapeutic intervention. High-output heart failure can be managed acutely with vasoconstricting agents, with focus on treating the underlying etiology. Disposition is not always straightforward, and several risk scores may assist in this decision.
CONCLUSION: AHF is a condition that requires rapid assessment and management. Understanding the appropriate management strategy can allow for more targeted treatment and improved outcomes. Published by Elsevier Inc.

Entities:  

Keywords:  diuretics; fluid overload; heart failure; nitroglycerine; noninvasive ventilation; pulmonary edema

Mesh:

Year:  2018        PMID: 30266198     DOI: 10.1016/j.jemermed.2018.08.002

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  6 in total

Review 1.  Diagnosis and Management of Acute Heart Failure in Sub-Saharan Africa.

Authors:  Alice Kidder Bukhman; Vizir Jean Paul Nsengimana; Mindy C Lipsitz; Patricia C Henwood; Endale Tefera; Shada A Rouhani; Damas Dukundane; Gene Y Bukhman
Journal:  Curr Cardiol Rep       Date:  2019-08-31       Impact factor: 2.931

2.  Evaluation of the HEFESTOS scale to predict outcomes in emergency department acute heart failure patients.

Authors:  Adriana Gil-Rodrigo; José María Verdú-Rotellar; Víctor Gil; Aitor Alquézar; Lluís Llauger; Pablo Herrero-Puente; Javier Jacob; Rosa Abellana; Miguel-Ángel Muñoz; María-Pilar López-Díez; Nicole Ivars-Obermeier; Begoña Espinosa; Beatriz Rodríguez; Marta Fuentes; Josep Tost; M Luisa López-Grima; Rodolfo Romero; Christian Müller; WFrank Peacock; Pere Llorens; Òscar Miró
Journal:  Intern Emerg Med       Date:  2022-08-29       Impact factor: 5.472

3.  Acute Hemodynamic Index Predicts In-Hospital Mortality in Acute Decompensated Heart Failure.

Authors:  Renata R T Castro; Luka Lechnewski; Alan Homero; Denilson Campos de Albuquerque; Luis Eduardo Rohde; Dirceu Almeida; João David; Salvador Rassi; Fernando Bacal; Edimar Bocchi; Lidia Moura
Journal:  Arq Bras Cardiol       Date:  2021-01       Impact factor: 2.000

Review 4.  Diagnosis of Acute Heart Failure in the Emergency Department: An Evidence-Based Review.

Authors:  Brit Long; Alex Koyfman; Michael Gottlieb
Journal:  West J Emerg Med       Date:  2019-10-24

Review 5.  Nitroglycerin Use in the Emergency Department: Current Perspectives.

Authors:  Michael J Twiner; John Hennessy; Rachel Wein; Phillip D Levy
Journal:  Open Access Emerg Med       Date:  2022-07-09

6.  Bioinformatics and In Silico Findings Uncover Bio-Targets of Calycosin Against Heart Failure and Diabetes Mellitus.

Authors:  Hongyuan Xu; Jingru Qin; Lixiu Qin; Chao Guo; Bin Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-08       Impact factor: 6.055

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.